Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome
- PMID: 18574218
- DOI: 10.1196/annals.1429.031
Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome
Abstract
Turner syndrome (TS) is a relatively common disorder of phenotypic females caused by loss of all or part of the second sex chromosome. Most individuals with TS have short stature and gonadal dysgenesis and are at risk for many other medical and learning problems. In the 45,X ovary, germs cells multiply quite normally during fetal development, but there is accelerated atresia of oocytes in the second half of pregnancy that produces gonadal insufficiency by birth. In girls with other karyotypes, especially those mosaic for 45,X/46,XX, gonadal function may be normal or near-normal. In this chapter, management goals for gonadal insufficiency in girls with TS are presented. The effects of estrogen deficiency and its replacement on three specific problems associated with TS-short stature, cardiovascular disease, and developmental differences in brain structure and function-are explored. General guidelines for estrogen replacement therapy using transdermal estrogen, the most physiologic option, are provided and future research goals are outlined.
Similar articles
-
Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.J Bone Miner Metab. 2002;20(5):294-7. doi: 10.1007/s007740200042. J Bone Miner Metab. 2002. PMID: 12203035 Clinical Trial.
-
Clinical practice in Turner syndrome.Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):41-52. doi: 10.1038/ncpendmet0024. Nat Clin Pract Endocrinol Metab. 2005. PMID: 16929365 Review.
-
Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.Growth Horm IGF Res. 2006 Jul;16 Suppl A:S91-7. doi: 10.1016/j.ghir.2006.04.002. Epub 2006 Jun 2. Growth Horm IGF Res. 2006. PMID: 16735135 Review.
-
Hormone replacement treatment in Turner syndrome.Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:214-8. Pediatr Endocrinol Rev. 2006. PMID: 16641863 Review.
-
[Spontaneous growth of girls with Turner's syndrome until 6 years of age].Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):7-11. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006. PMID: 16704855 Polish.
Cited by
-
Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications.J Clin Oncol. 2013 Mar 20;31(9):1239-47. doi: 10.1200/JCO.2012.43.5511. Epub 2013 Feb 4. J Clin Oncol. 2013. PMID: 23382474 Free PMC article. Review.
-
Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.BMJ. 2011 Apr 14;342:d1980. doi: 10.1136/bmj.d1980. BMJ. 2011. PMID: 21493672 Free PMC article. Clinical Trial.
-
Psychosocial functioning and social cognitive processing in girls with Turner syndrome.J Dev Behav Pediatr. 2011 Sep;32(7):512-20. doi: 10.1097/DBP.0b013e3182255301. J Dev Behav Pediatr. 2011. PMID: 21743350 Free PMC article.
-
Effects of growth hormone on body proportions in Turner syndrome compared with non-treated patients and normal women.J Endocrinol Invest. 2010 Nov;33(10):691-5. doi: 10.1007/BF03346671. Epub 2010 Mar 30. J Endocrinol Invest. 2010. PMID: 20354352
-
Late endocrine effects of childhood cancer.Nat Rev Endocrinol. 2016 Jun;12(6):319-36. doi: 10.1038/nrendo.2016.45. Epub 2016 Apr 1. Nat Rev Endocrinol. 2016. PMID: 27032982 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical